Biomarker profiling to determine clinical impact of microRNAs in cognitive disorders

Biomarker profiling to determine clinical impact of microRNAs in cognitive disorders

Abstract Alzheimer’s disease (AD) and post-stroke cognitive impairment (PSCI) are the leading causes of progressive dementia related to neurodegenerative and cerebrovascular injuries in elderly populations. Despite decades of research, patients with these conditions still lack minimally invasive, lo...

Full description

Bibliographic Details
Main Authors: Weijie Zhai, Meng Zhao, Chunxiao Wei, Guimei Zhang, Yiming Qi, Anguo Zhao, Li Sun
Format: Article
Language:English
Published: Nature Portfolio 2024-04-01
Series:Scientific Reports
Subjects:
Alzheimer’s disease
Bioinformatics
Cognitive impairment
Dementia
Post-stroke cognitive impairment
MicroRNA
Online Access:https://doi.org/10.1038/s41598-024-58882-2

Internet

https://doi.org/10.1038/s41598-024-58882-2

Similar Items